Tulane Pediatrics Infectious Disease Research focuses on advancing the understanding, prevention, and treatment of infectious diseases affecting children, both locally and globally. The program integrates clinical care, laboratory science, and public health to address critical pediatric infections, particularly in vulnerable and resource-limited populations.
Research efforts span a wide range of conditions, including HIV/AIDS, tuberculosis, emerging viral infections (such as Ebola, dengue, and Zika), and pediatric diarrheal and respiratory diseases. Investigators conduct clinical trials, epidemiologic studies, and diagnostic innovation to improve outcomes and develop new therapies and vaccines.
A strong emphasis is placed on global health, with active research collaborations in regions such as Africa, Southeast Asia, and South America. These initiatives address infectious disease burden, maternal-child health, and health system strengthening in underserved communities.
The program is highly collaborative, partnering with the Tulane School of Public Health and Tropical Medicine, the Center for Infectious Diseases, and international research sites. Faculty are supported by substantial NIH funding and contribute to multidisciplinary efforts that bridge clinical medicine and population health.
Through its integrated approach, Tulane Pediatrics Infectious Disease Research is dedicated to improving pediatric health outcomes worldwide while training the next generation of clinician-scientists in infectious diseases.